← All organizations
Highest phase reached
Phase 4
First clinical trial
Mar 1, 2012Last known activity
Sep 29, 2025
Timeline
1960s
- Jan 1, 1966
Serum Institute of India Pvt. Ltd.— Founded
Drugs by trial phase (27 distinct, 27 trials)
Phase 4 (4 own, 0 via acquisition)
Phase 3 (14 own, 0 via acquisition)
- bacille calmette-guerin
- DTaP, inactivated poliovirus, haemophilus influenzae b conjugate, hepatitis b vaccine
- human papillomavirus quadrivalent (types 6, 11, 16 and 18) vaccine, recombinant
- rotavirus vaccine, live, oral, pentavalent
- yellow fever vaccine 17d strain
- Haemophilus influenzae Type b Conjugate and Hepatitis B (Recombinant)
- dipropyltryptamine
- brv-pv
- meningococcal (groups A, C, Y, W) tetanus toxoid conjugate vaccine
- bivalent oral polio vaccine (bopv), type 1 and type 3
- polio, inactivated poliovirus vaccine
- human rotavirus, live attenuated
- nmcv-5
- inactivated sabin strain polio virus
Phase 2 (6 own, 0 via acquisition)
Phase 1 (3 own, 0 via acquisition)
Indications
Recent trials (33)
- NCT07216430CollaboratorPhase 2Sep 29, 2025
- NCT07147400Lead sponsorPhase 2Aug 22, 2025
- NCT06507605Lead sponsorPhase 1Jul 30, 2024
- NCT06281119Lead sponsorPhase 3Jun 30, 2024
- NCT06413121Lead sponsorPhase 3May 6, 2024
- NCT05447377Lead sponsorPhase 3Jul 30, 2022
- NCT05421611Lead sponsorPhase 3Jul 25, 2022
- NCT05163561Lead sponsorPhase 3Jan 10, 2022
- NCT04439045CollaboratorPhase 3Jun 14, 2020
- NCT04351685Study directorPhase 3Jun 10, 2020
- NCT04351685Lead sponsorPhase 3Jun 10, 2020
- NCT04358731Study directorPhase 2/Phase 3Dec 27, 2019
- NCT04358731Lead sponsorPhase 2/Phase 3Dec 27, 2019
- NCT04035278Study directorPhase 1Sep 1, 2019
- NCT04035278Lead sponsorPhase 1Sep 1, 2019
Details
- Founded
- Pune, IN Jan 1, 1966
- Last known activity
- Sep 29, 2025